BIOMARIN PHARMACEUTICAL INC (BMRN) Interest Expense USD 2010 - 2024

Historical data

Taxonomy & unit
us-gaap: USD
Description
Amount of the cost of borrowed funds accounted for as interest expense.
Summary
Biomarin Pharmaceutical Inc quarterly/annual Interest Expense history and growth rate from 2010 to 2024.
  • Biomarin Pharmaceutical Inc Interest Expense for the quarter ending March 31, 2024 was $3.55 M, a 4.21% decline year-over-year.
  • Biomarin Pharmaceutical Inc Interest Expense for the twelve months ending March 31, 2024 was $17.2 M, a 8.27% increase year-over-year.
  • Biomarin Pharmaceutical Inc annual Interest Expense for 2023 was $17.3 M, a 8.55% increase from 2022.
  • Biomarin Pharmaceutical Inc annual Interest Expense for 2022 was $16 M, a 4.13% increase from 2021.
  • Biomarin Pharmaceutical Inc annual Interest Expense for 2021 was $15.3 M, a 47.7% decline from 2020.
Interest Expense, Trailing 12 Months (USD)
Interest Expense, Quarterly Data (USD)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 $17.2 M $3.55 M -$156 K -4.21% Jan 1, 2024 Mar 31, 2024 10-Q 2024-04-26
Q4 2023 $17.3 M $6.1 M +$2.47 M +68.2% Oct 1, 2023 Dec 31, 2023 10-K 2024-02-26
Q3 2023 $14.9 M $3.78 M -$900 K -19.2% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-02
Q2 2023 $15.8 M $3.76 M -$104 K -2.7% Apr 1, 2023 Jun 30, 2023 10-Q 2023-08-02
Q1 2023 $15.9 M $3.7 M -$103 K -2.71% Jan 1, 2023 Mar 31, 2023 10-Q 2024-04-26
Q4 2022 $16 M $3.63 M -$220 K -5.72% Oct 1, 2022 Dec 31, 2022 10-K 2024-02-26
Q3 2022 $16.2 M $4.68 M +$809 K +20.9% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-02
Q2 2022 $15.4 M $3.86 M +$42 K +1.1% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-02
Q1 2022 $15.3 M $3.81 M +$2 K +0.05% Jan 1, 2022 Mar 31, 2022 10-Q 2023-04-28
Q4 2021 $15.3 M $3.85 M -$903 K -19% Oct 1, 2021 Dec 31, 2021 10-K 2024-02-26
Q3 2021 $16.2 M $3.87 M -$5.73 M -59.7% Jul 1, 2021 Sep 30, 2021 10-Q 2022-10-28
Q2 2021 $22 M $3.82 M -$4.23 M -52.6% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-04
Q1 2021 $26.2 M $3.8 M -$3.11 M -45% Jan 1, 2021 Mar 31, 2021 10-Q 2022-04-29
Q4 2020 $29.3 M $4.75 M -$2.18 M -31.5% Oct 1, 2020 Dec 31, 2020 10-K 2023-02-27
Q3 2020 $31.5 M $9.6 M +$6.66 M +227% Jul 1, 2020 Sep 30, 2020 10-Q 2021-10-29
Q2 2020 $24.8 M $8.05 M +$1.18 M +17.2% Apr 1, 2020 Jun 30, 2020 10-Q 2021-07-30
Q1 2020 $23.6 M $6.92 M +$188 K +2.8% Jan 1, 2020 Mar 31, 2020 10-Q 2021-04-30
Q4 2019 $23.5 M $6.93 M -$816 K -10.5% Oct 1, 2019 Dec 31, 2019 10-K 2022-02-25
Q3 2019 $24.3 M $2.94 M -$9.19 M -75.8% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-06
Q2 2019 $33.5 M $6.87 M -$5.36 M -43.8% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-05
Q1 2019 $38.8 M $6.73 M -$4.84 M -41.8% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-01
Q4 2018 $43.7 M $7.75 M -$3.92 M -33.6% Oct 1, 2018 Dec 31, 2018 10-K 2021-02-26
Q3 2018 $47.6 M $12.1 M +$1.25 M +11.5% Jul 1, 2018 Sep 30, 2018 10-Q/A 2019-11-04
Q2 2018 $46.3 M $12.2 M +$2.19 M +21.8% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-02
Q1 2018 $44.2 M $11.6 M +$1.44 M +14.3% Jan 1, 2018 Mar 31, 2018 10-Q 2019-04-29
Q4 2017 $42.7 M $11.7 M +$1.93 M +19.9% Oct 1, 2017 Dec 31, 2017 10-K 2020-02-27
Q3 2017 $40.8 M $10.9 M +$904 K +9.06% Jul 1, 2017 Sep 30, 2017 10-Q 2018-10-26
Q2 2017 $39.9 M $10 M +$96 K +0.97% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-03
Q1 2017 $39.8 M $10.1 M +$276 K +2.8% Jan 1, 2017 Mar 31, 2017 10-Q 2018-04-27
Q4 2016 $39.5 M $9.73 M +$399 K +4.28% Oct 1, 2016 Dec 31, 2016 10-K 2019-02-28
Q3 2016 $39.1 M $9.98 M +$533 K +5.64% Jul 1, 2016 Sep 30, 2016 10-Q 2017-10-31
Q2 2016 $38.6 M $9.94 M -$58 K -0.58% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-02
Q1 2016 $38.6 M $9.84 M +$381 K +4.03% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-04
Q4 2015 $38.2 M $9.33 M +$136 K +1.48% Oct 1, 2015 Dec 31, 2015 10-K 2018-02-26
Q3 2015 $38.1 M $9.45 M +$329 K +3.61% Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-03
Q2 2015 $37.8 M $10 M +$781 K +8.47% Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-08
Q1 2015 $37 M $9.46 M +$356 K +3.91% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-02
Q4 2014 $36.6 M $9.2 M +$1.6 M +21.1% Oct 1, 2014 Dec 31, 2014 10-K 2017-02-27
Q3 2014 $35 M $9.12 M +$8.59 M +1633% Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-02
Q2 2014 $26.4 M $9.22 M +$8.62 M +1429% Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-05
Q1 2014 $17.8 M $9.11 M +$7.38 M +428% Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-05
Q4 2013 $10.4 M $7.59 M +$5.66 M +293% Oct 1, 2013 Dec 31, 2013 10-K 2016-02-29
Q3 2013 $4.78 M $526 K -$1.31 M -71.4% Jul 1, 2013 Sep 30, 2013 10-Q 2014-10-28
Q2 2013 $6.1 M $603 K -$1.32 M -68.7% Apr 1, 2013 Jun 30, 2013 10-Q 2014-07-31
Q1 2013 $7.42 M $1.73 M -$222 K -11.4% Jan 1, 2013 Mar 31, 2013 10-Q 2014-05-02
Q4 2012 $7.64 M $1.93 M +$53 K +2.82% Oct 1, 2012 Dec 31, 2012 10-K 2015-03-02
Q3 2012 $7.59 M $1.84 M -$331 K -15.3% Jul 1, 2012 Sep 30, 2012 10-Q 2013-10-28
Q2 2012 $7.92 M $1.93 M -$276 K -12.5% Apr 1, 2012 Jun 30, 2012 10-Q 2013-07-29
Q1 2012 $8.19 M $1.95 M -$216 K -9.99% Jan 1, 2012 Mar 31, 2012 10-Q 2013-04-29
Q4 2011 $8.41 M $1.88 M -$869 K -31.6% Oct 1, 2011 Dec 31, 2011 10-K 2014-02-26
Q3 2011 $9.28 M $2.17 M -$840 K -27.9% Jul 1, 2011 Sep 30, 2011 10-Q 2012-10-29
Q2 2011 $10.1 M $2.2 M -$434 K -16.5% Apr 1, 2011 Jun 30, 2011 10-Q 2012-08-02
Q1 2011 $10.6 M $2.16 M -$266 K -11% Jan 1, 2011 Mar 31, 2011 10-Q 2012-04-30
Q4 2010 $10.8 M $2.75 M Oct 1, 2010 Dec 31, 2010 10-K 2013-02-26
Q3 2010 $3.01 M Jul 1, 2010 Sep 30, 2010 10-Q 2011-10-31
Q2 2010 $2.64 M Apr 1, 2010 Jun 30, 2010 10-Q 2011-08-01
Q1 2010 $2.43 M Jan 1, 2010 Mar 31, 2010 10-Q 2011-04-29
* An asterisk sign (*) next to the value indicates that the value is likely invalid.